Please assess the completion status of the following clinical trial:

Trial Title: A Phase II , Placebo-controlled Study to Assess Efficacy of 28 Day Oral AZD9668 in Patients With Bronchiectasis

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: BASIC_SCIENCE
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Female of non child bearing potential~* Clinical diagnosis of bronchiectasis~* Be sputum producers, with history of chronic expectoration on most days~Exclusion Criteria:~* Concomitant diagnosis of pulmonary disease other than bronchiectasis or COPD~* FEV1 of \<30% of predicted normal

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 80 Years
- Healthy Volunteers: f

Study Arms:
- AZD9668 active treatment (Type: EXPERIMENTAL): None
- AZD9668 placebo treatment (Type: PLACEBO_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).